Clinical challenges in de novo pediatric acute myeloid leukemia

K Klein, V de Haas, GJL Kaspers - Expert Review of Anticancer …, 2018 - Taylor & Francis
Introduction: Although the prognosis of pediatric acute myeloid leukemia (pAML) has
improved, with current survival rates up to 75%, relapse rates remain high. Areas covered …
被引用次数：36 相关文章

Clinical challenges in de novo pediatric acute myeloid leukemia

K Klein, V de Haas… - Expert Review …, 2018 - researchinformation.amsterdamumc …
Introduction: Although the prognosis of pediatric acute myeloid leukemia (pAML) has
improved, with current survival rates up to 75%, relapse rates remain high. Areas covered …

Clinical challenges in de novo pediatric acute myeloid leukemia.

K Klein, V de Haas, GJL Kaspers - Expert Review of Anticancer …, 2018 - europepmc.org
INTRODUCTION: Although the prognosis of pediatric acute myeloid leukemia (pAML) has
improved, with current survival rates up to 75%, relapse rates remain high. Areas covered …
[PDF] vu.nl

[PDF][PDF] Clinical challenges in de novo pediatric acute myeloid leukemia

K Klein, V de Haas, GJL Kaspers - VU Research Portal - research.vu.nl
Although the prognosis of pediatric acute myeloid leukemia (pAML) has improved with
current survival rates up to 75%, relapse rates remain high. The low number of patients, the …

Clinical challenges in de novo pediatric acute myeloid leukemia

K Klein, V de Haas… - Expert review of …, 2018 - pubmed.ncbi.nlm.nih.gov
Although the prognosis of pediatric acute myeloid leukemia (pAML) has improved, with
current survival rates up to 75%, relapse rates remain high. Areas covered: The low number …
[PDF] academia.edu

[PDF][PDF] Clinical challenges in de novo pediatric acute myeloid leukemia

K Klein, V de Haas, GJL Kaspers - 2018 - academia.edu
Introduction: Although the prognosis of pediatric acute myeloid leukemia (pAML) has
improved, with current survival rates up to 75%, relapse rates remain high. Areas covered …